SI1075477T1 - Novel Benzonaphthyridine-N-oxides - Google Patents

Novel Benzonaphthyridine-N-oxides

Info

Publication number
SI1075477T1
SI1075477T1 SI9930279T SI9930279T SI1075477T1 SI 1075477 T1 SI1075477 T1 SI 1075477T1 SI 9930279 T SI9930279 T SI 9930279T SI 9930279 T SI9930279 T SI 9930279T SI 1075477 T1 SI1075477 T1 SI 1075477T1
Authority
SI
Slovenia
Prior art keywords
oxides
hand
benzonaphthyridine
novel
novel benzonaphthyridine
Prior art date
Application number
SI9930279T
Other languages
English (en)
Slovenian (sl)
Inventor
Beate Gutterer
Hermann Amschler
Wolf-R�diger ULRICH
Thomas Martin
Thomas Br
Armin Hatzelmann
Hildegard Boss
Rolf Beume
Daniela Bundschuh
Hans-Peter Kley
Dieter Flockerzi
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of SI1075477T1 publication Critical patent/SI1075477T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Glass Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
SI9930279T 1998-05-05 1999-04-27 Novel Benzonaphthyridine-N-oxides SI1075477T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98108124 1998-05-05
EP99922133A EP1075477B1 (de) 1998-05-05 1999-04-27 Neue Benzonaphtyridin-N-oxide
PCT/EP1999/002827 WO1999057118A1 (de) 1998-05-05 1999-04-27 Neue n-oxide

Publications (1)

Publication Number Publication Date
SI1075477T1 true SI1075477T1 (en) 2003-08-31

Family

ID=8231880

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930279T SI1075477T1 (en) 1998-05-05 1999-04-27 Novel Benzonaphthyridine-N-oxides

Country Status (12)

Country Link
US (1) US6306869B1 (xx)
EP (1) EP1075477B1 (xx)
JP (1) JP2002513793A (xx)
AT (1) ATE234301T1 (xx)
AU (1) AU3928999A (xx)
CA (1) CA2330738A1 (xx)
DE (1) DE59904535D1 (xx)
DK (1) DK1075477T3 (xx)
ES (1) ES2195571T3 (xx)
PT (1) PT1075477E (xx)
SI (1) SI1075477T1 (xx)
WO (1) WO1999057118A1 (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1109810T3 (da) 1998-08-31 2004-10-18 Altana Pharma Ag Benzonaphthydin-N-oxider med PDE3- og PDE4-inhiberende aktivitet
EA006685B1 (ru) * 1999-08-21 2006-02-24 Алтана Фарма Аг Синергетическая композиция
DE60133879D1 (de) 2000-01-11 2008-06-19 Nycomed Gmbh Phenanthridin -n- oxide
DK1377574T3 (da) * 2001-02-21 2005-04-25 Altana Pharma Ag 6-phenylbenzonaphtyridiner
PL373598A1 (en) * 2002-08-17 2005-09-05 Altana Pharma Ag Novel benzonaphthyridines
WO2004019944A1 (en) 2002-08-29 2004-03-11 Altana Pharma Ag 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
ES2281658T3 (es) * 2002-08-29 2007-10-01 Nycomed Gmbh 3-hidroxi-6-fenilfenantridinas como inhibidores de pde-4.
US7470704B2 (en) * 2002-09-04 2008-12-30 Nycomed Gmbh Benzonaphthyridines
ATE360021T1 (de) * 2002-09-04 2007-05-15 Altana Pharma Ag Neue benzonaphthyridine
IS7839A (is) * 2002-11-22 2004-05-23 Merck Frosst Canada Ltd. 4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar
JP4728259B2 (ja) * 2004-02-18 2011-07-20 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 効果的なホスホジエステラーゼ(pde)4インヒビターとしての新規のグアニジニル置換されたヒドロキシ−6−フェニルフェナントリジン
WO2005085225A1 (en) 2004-03-03 2005-09-15 Altana Pharma Ag Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
AU2005220034A1 (en) * 2004-03-09 2005-09-15 Nycomed Gmbh Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
EP1725534A1 (en) * 2004-03-10 2006-11-29 Altana Pharma AG Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
WO2005087744A1 (en) * 2004-03-10 2005-09-22 Altana Pharma Ag Novel thio-containing hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
WO2005085203A1 (en) * 2004-03-10 2005-09-15 Altana Pharma Ag Novel difluoroethoxy-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
EP1732925A1 (en) * 2004-03-17 2006-12-20 Altana Pharma AG Novel n-(alkoxyalkyl)carbamoyl- substituted 6-phenyl-benzonaphthyridine derivatives and their use as pde3/4 inhibitors
US7589205B2 (en) * 2004-09-08 2009-09-15 Nycomed Gmbh 3-thia-10-aza-phenanthrene derivatives
ATE508130T1 (de) 2004-09-08 2011-05-15 Nycomed Gmbh 3-oxa-10-aza-phenanthrene als pde4- oder pde3/4- inhibitoren
NZ560268A (en) 2005-03-02 2010-12-24 Nycomed Gmbh Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス,インコーポレイティド Pde阻害による神経新生の調節
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド 5ht受容体介在性の神経新生
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247971A3 (en) * 1986-05-29 1990-01-17 Sandoz Ag Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin
ES2195189T3 (es) 1996-11-11 2003-12-01 Altana Pharma Ag Benzonaftiridinas como agentes terapeuticos bronquiales.

Also Published As

Publication number Publication date
AU3928999A (en) 1999-11-23
PT1075477E (pt) 2003-07-31
US6306869B1 (en) 2001-10-23
CA2330738A1 (en) 1999-11-11
DK1075477T3 (da) 2003-06-30
JP2002513793A (ja) 2002-05-14
ES2195571T3 (es) 2003-12-01
EP1075477B1 (de) 2003-03-12
EP1075477A1 (de) 2001-02-14
ATE234301T1 (de) 2003-03-15
DE59904535D1 (de) 2003-04-17
WO1999057118A1 (de) 1999-11-11

Similar Documents

Publication Publication Date Title
SI1075477T1 (en) Novel Benzonaphthyridine-N-oxides
CA2297911A1 (en) Substituted 6-phenylphenanthridines
PL334561A1 (en) Novel phtalysinones
SI1070056T1 (en) Phthalazinone pde iii/iv inhibitors
ES2195785A1 (es) Nuevos derivados de piridazin-3(2h)-ona.
TR200400702T4 (tr) AMP özgü fosfodiesteraz inhibtörleri olarak 3-tiazol-4-il-pirolidin türevleri.
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
WO2003087088A3 (en) (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them
PL338339A1 (en) Novel derivatives of tetrazole
DK1109810T3 (da) Benzonaphthydin-N-oxider med PDE3- og PDE4-inhiberende aktivitet
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
PT1147103E (pt) Fenantridina-n-oxidos com actividade inibitoria de pde-iv
SI1147087T1 (en) Phenanthridine-n-oxides with pde-iv inhibiting activity
MXPA02012263A (es) 5-aminoalquil-pirazol[4,3-d]pirimidinas.
WO2002051848A3 (de) Sulfamidothienopyrimidine zur verwendung als phosphodiesterase v-hemmer
SI1377574T1 (xx)
MXPA02012260A (es) 2-aminoalquil-tieno[2,3-d]pirimidinas.